Immunofluorescence study comparing the effects of individual LA, OC, and OC-LA combination treatments versus VC on the tumor progression marker Ki-67 expression and the vascular endothelial vasculogenesis marker CD31. This evidence concerns the gene PECAM1 and neoplasm.